
    
      The purpose of our study was to evaluate the diagnostic ability of CEUS with perflubutane to
      identify HCC on the indeterminate observation in Gd-EOB-MRI and to establish the role of CEUS
      as a second-line (post-Gd-EOB-MRI) modality for HCC diagnosis.
    
  